Studies have long warned that blows to the head may raise the risk of neurodegenerative conditions. Now, scientists believe ...

Consider Dexmedetomidine Dexmedetomidine, a sedative commonly used during surgeries, has shown promise in reducing the risk ...

Americans reach the age of 65 every day. Though many older adults are in good health, there are many others who are facing ...

Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

Rose Schwartz, left, whose husband Buddy died of cancer while under hospice care from Medi Home Hospice, is thankful for the ...

Consistent with the approach taken by other alternative payment models, GUIDE frames the emergency department as a negative ...

A first-of-its-kind study has shown how and why music is able to reduce distress and agitation for people with advanced ...

Some end-of-life clinicians are concerned about antipsychotics' effectiveness compared with other treatment options.

With two earlier trials meeting their primary endpoints, Axsome claimed it has the data to support a filing for FDA approval ...

Readers were enthusiastic, but commentators did not hesitate to share their thoughts and personal experiences.

ITI-1284 is under clinical development by Intra-Cellular Therapies and currently in Phase II for Generalized Anxiety Disorder (GAD).

ACCORD-2 Phase 3 trial in Alzheimer’s disease agitation achieves primary endpoint compared to placebo (p=0.001, time to relapse)ACCORD-2 Phase 3 ...